ATS 2024 Final Program

Click on the session title to view the speakers

12

SATURDAY • MAY 18

8:35 Environmental and Microbiome Interactions in Asthma: Beyond Allergens and Viruses 9:05 Type 2 Inflammation in COPD 9:35 Type 2 Inflammation in Non-Asthmatic Disorders - Vasculitis, CF, Other Organs 10:05 Break 10:20 Non-Type 2 Asthma - Mechanisms 10:50 Small Airways Dysfunction in Asthma and COPD 11:20 Molecular Phenotyping in Asthma 11:50 Lunch 1:00 Disparities in Asthma Epidemiology and Treatment 1:30 Pediatric Asthma - Special Considerations and Treatment 2:00 Current Asthma Management Highlights - Which Biologic for Which Patient? 2:30 New Therapeutic Targets for Asthma 3:00 Break 3:15 Case Discussion with Faculty Panel PG14 INTERSTITIAL LUNG DISEASE: IMPLEMENTING GUIDELINES FOR PATIENT CENTERED CARE R Pre-registration and additional fees required. Attendance is limited. Member: $455 In-Training Member: $265 LMIC Member: $320 LMIC In-Training Member: $190 Non-Member: $560 In-Training Non-Member: $395 Assemblies on Clinical Problems; Allergy, Immunology and Inflammation; Behavioral and Health Services Research; Nursing; Pulmonary Circulation; Pulmonary Rehabilitation 8:00 a.m. - 4:00 p.m. San Diego Convention Center Room 2 (Upper Level) Target Audience This session should be broadly relevant to those who provide clinical care for patients with ILD including pulmonary fellows, general pulmonologists, ILD specialists, and advanced care nurses. CLINICAL POSTGRADUATE COURSE

BASIC • CLINICAL • TRANSLATIONAL POSTGRADUATE COURSE

PG13 TYPE 2 ASTHMA AND BEYOND: MOLECULAR MECHANISMS, PHYSIOLOGY, AND TREATMENT R Pre-registration and additional fees required. Attendance is limited. Member: $455 In-Training Member: $265 LMIC Member: $320 LMIC In-Training Member: $190 Non-Member: $560 In-Training Non-Member: $395 Assemblies on Allergy, Immunology and Inflammation; Respiratory Cell and Molecular Biology 8:00 a.m. - 4:00 p.m. San Diego Convention Center Room 8 (Upper Level) Target Audience Clinicians, clinical investigators, and basic investigators focused on immune-mediated airways disease such as asthma and COPD as well as lung immunology in general. Objectives At the conclusion of this session, the participant will be able to: • understand mechanisms of airway inflammation with a focus on type 2 inflammation. Review methods for scientific investigation in immune-mediated airway disease such as asthma and COPD • understand the physiology and environmental factors that drive asthma and COPD pathophysiology • discuss the current and future state of advanced therapies for asthma and COPD. Special sessions dedication to discussion of disparities in therapy and considerations for pediatric asthma This session will provide a state of the art summary of the current understanding of the mechanisms, physiology and management of immune mediated airway diseases such as asthma and COPD, with a focus on type 2 inflammation. The course will also present a comprehensive review of the factors that influence disease progression and the current management paradigm. 8:00 Welcome 8:05 The Immunology of Type 2 Inflammation in Asthma: What a Pulmonologist Needs to Know

ATS 2024 Conference Program • San Diego, CA